跳至主要内容
临床试验/NCT05116839
NCT05116839Unknown不适用

Pressure Support Ventilation Versus Continuous Positive Air Way Pressure (CPAP) Using I Gel Laryngeal Mask for Minor Surgery in Adult Patients, a Prospective cross_over Study

Mansoura University1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2019年3月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
38
试验地点
1
主要终点
Effective ventilation with PSV than does (CPAP) as regard Leakage %

研究概览

简要总结

Introduction of Supra glottic airway devices (SAD) has revolutionized the airway management. The first successful supraglottic airway device, the Laryngeal Mask Airway(LMA).The various other SADs include ProSeal LMA, Intubating LMA and i-gel to overcome the limitations of classic Laryngeal Mask Airway( c-LMA) The risk of aspiration with c-LMA is reported tobe around 9% , pleaseboth the c-LMA and PLMA have cuff related complications. High cuff pressure in laryngeal mask airways can cause damage to the mucosae on periglottic and supraglottic structures .

Therefore, to overcome the limitations of Pro Seal Laryngeal Mask Airway (PLMA )a new and cheaper SAD called i-gel was developed. i-gel is a novel and innovative, latex free supraglottic device, made up of medical grade thermoplastic elastomer, which is soft, gel like, transparent The number of manipulations required are more in PLMA than i gel resulting in hemodynamic changes .The i-gel is comparable to PLMA insuring the airway during controlled ventilation. It is better than PLMA in terms of ease of insertion.

Spontaneous breathing is the most popular mode of ventilation with the laryngeal mask airway (LMA), but it provides less effective gas exchange than does positive pressure ventilation (PPV) . The patients receiving sevoflurane anesthesia with unassisted ventilation have a reduced rib cage contribution to ventilation, decreased tidal volume, and respiratory rate .

Pressure support ventilation (PSV) is a ventilator mode that is initiated by the patient and synchronized with the patient's respiratory effort. And may improve gaseous exchange in patients. In the intensive care unit, it is often considered the preferred mode for weaning mechanical ventilation .PSV provides more effective gas exchange than does unassisted ventilation with CPAP during anesthesia with the LMA while preserving hemodynamic homeostasis.

The use of PSV versus CPAP with the Pro Seal laryngeal mask airway in anesthetized pediatric patients revealed that PSV improved gaseous exchange and reduced work of breathing during general anesthesia PSV via Pro- Seal laryngeal mask airway improves gaseous exchange and ventilation in pediatric patients under general anesthesia more than spontaneous ventilation .

详细描述

Patients and Methods This prospective,cross over study will be conducted after obtaining approval from the Institutional Review Board (IRB) of faculty of medicine Mansoura University. A written informed consent will be obtained from all participants and the duration of the study will be 2 - 6 months.

Participants:

38 Adult patients with American Society of Anesthesiologists (ASA) physical status (I - II )of both sexes aged (18-65) years scheduled for minor surgery at Urology and Nephrology centre (UNC) will be included in this study.

The Patients with a body mass index (BMI) >40 or having obstructive air way disease will be excluded.

All patients will be assessed on the day before surgery by detailed history thorough clinical examination, and basal laboratory investigations [Complete blood count (CBC), Coagulation profile (prothrombin time and INR), liver and renal function tests (liver enzymes, bilirubin, albumin and s. creatinine], electrocardiograph (ECG) and echo cardiography when needed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients with (ASA) physical status I - II years scheduled for minor surgery at Urology and Nephrology centre (UNC) will be included in this study.

排除标准

  • •The Patients with a body mass index (BMI) >40 or having obstructive air way disease will be excluded.•

研究组 & 干预措施

the first 15 minutes with PSV

Placebo Comparator

All patients will breath at the first 15 minutes with PSV:triggered by minute volume <3 Liter,with with no frequency .

Monitoring: (basal&every 3minutes)

  1. Tidal volume (inspiratory & expiratory).
  2. End tidal co2.
  3. Mean air way pressure.
  4. Leakage %.
  5. Respiratory rate .
  6. Spo2.
  7. Heart rate.
  8. Blood pressure (mean arterial pressure

干预措施: the first 15 minutes with pressure support ventilation (Device)

the first 15 minutes with PSV

Placebo Comparator

All patients will breath at the first 15 minutes with PSV:triggered by minute volume <3 Liter,with with no frequency .

Monitoring: (basal&every 3minutes)

  1. Tidal volume (inspiratory & expiratory).
  2. End tidal co2.
  3. Mean air way pressure.
  4. Leakage %.
  5. Respiratory rate .
  6. Spo2.
  7. Heart rate.
  8. Blood pressure (mean arterial pressure

干预措施: i gel air way (Device)

the following 15 minutes ventilation will be changed to CPAP mode

Active Comparator

then the following 15 minutes ventilation will be changed to CPAP mode at 10 cm H2o .

Monitoring: (basal&every 3minutes)

  1. Tidal volume (inspiratory & expiratory).
  2. End tidal co2.
  3. Mean air way pressure.
  4. Leakage %.
  5. Respiratory rate .
  6. Spo2.
  7. Heart rate.
  8. Blood pressure (mean arterial pressure).

干预措施: the following 15 minutes ventilation will be changed to continous positive air way pressureCPAP mode (Device)

the following 15 minutes ventilation will be changed to CPAP mode

Active Comparator

then the following 15 minutes ventilation will be changed to CPAP mode at 10 cm H2o .

Monitoring: (basal&every 3minutes)

  1. Tidal volume (inspiratory & expiratory).
  2. End tidal co2.
  3. Mean air way pressure.
  4. Leakage %.
  5. Respiratory rate .
  6. Spo2.
  7. Heart rate.
  8. Blood pressure (mean arterial pressure).

干预措施: i gel air way (Device)

结局指标

主要结局

Effective ventilation with PSV than does (CPAP) as regard Leakage %

时间窗: 30 minutes

Breathing of all patients at the first 15 minutes with PSVpressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) Leakage % on ventilator monitor

Effective ventilation with PSV than does CPAP as regard Mean air way pressure

时间窗: 30 minutes

Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) Mean air way pressure.on ventilator mmhg

Effective ventilation with PSV than does CPAP as regard oxygen saturation.

时间窗: 30 minutes

Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) oxygen saturation.on monitoring in %

Effective ventilation with PSV than does (CPAP) as regard respiratory rate

时间窗: 30 minutes

Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal\& every 3minute)respiratory rate on monitor breath/ minute

Effective ventilation with PSV than does (CPAP) as regard Tidal volume

时间窗: 30 minutes

Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal\& every 3minutes)Tidal volume (inspiratory \& expiratory).on ventilator monitor in mil/ kilogram

Effective ventilation with PSV than does (CPAP) as regard End tidal co2. on ventilator

时间窗: 30 minutes

Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume \<3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal\& every 3minutes) End tidal co2. on ventilator ml/eq

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marwa Ibrahim Mohamed Abdo,MD

Lecturer of Anesthesia and Surgical Intensive Care-Faculty of Medicine - Mansoura University

Mansoura University

研究点 (1)

Loading locations...

相似试验